4.8 (763) · $ 16.50 · In stock
A comprehensive review about SARS-CoV-2
Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight
View of Phytochemicals: Potential Lead Compounds for COVID-19 Therapeutics
Viruses, Free Full-Text
COVID-19, Infection Cycle
SARS-CoV-2 origin, myths and diagnostic technology developments, Egyptian Journal of Medical Human Genetics
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients, Virology Journal
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection
Molecules, Free Full-Text
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications, Journal of Biomedical Science
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications, Journal of Biomedical Science
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19